Physician
Endocrinology
Dr. Maria E. Cabanillas, MD
|
|
Give Review
Maria Cabanillas practices Endocrinology. He researched medicine at University of Puerto Rico School of Medicine. Dr. Maria E. Cabanillas is a published doctor and has 40 publications published. The lastest was: 'Treatment and survival of patients with insular thyroid carcinoma: 508 cases from the National Cancer Data Base.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Preexisting Adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis.
- Treatment and survival of patients with insular Thyroid carcinoma: 508 cases from the National Cancer Data Base.
- Thyroid Gland Malignancies.
- Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary Thyroid cancer: M.D. Anderson Cancer Center off label experience.
- BRAF Inhibitors: Experience in Thyroid Cancer and General Review of Toxicity.
- BRAF inhibitor dabrafenib in patients with metastatic BRAF-mutant Thyroid cancer.
- Medullary Thyroid Cancer in the Era of Tyrosine Kinase Inhibitors: To Treat or Not to Treat-And with Which Drug-Those Are the Questions.
- A Phase I Study of Cabozantinib (XL184) in Patients with Differentiated Thyroid Cancer.
- Role of salvage targeted therapy in differentiated Thyroid cancer patients who failed first-line sorafenib.
- THERAPY OF ENDOCRINE DISEASE: Treatment of malignant pheochromocytoma and paraganglioma.
- Measuring the Extent of Total Thyroidectomy for Differentiated Thyroid Carcinoma Using Radioactive Iodine Imaging: Relationship With Serum Thyroglobulin and Clinical O...
- Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients With Differentiated Thyroid Cancer.
- Aerodigestive Fistula Formation as a Rare Side Effect of Antiangiogenic Tyrosine Kinase Inhibitor Therapy for Thyroid Cancer.
- Sorafenib in Metastatic Thyroid Cancer: A Systematic Review.
- Current update on medullary Thyroid carcinoma.
- Clinical Responses to Vemurafenib in Patients with Metastatic Papillary Thyroid Cancer Harboring V600EBRAF Mutation.
- Optimizing therapy for radioactive io-dine-refractory differentiated Thyroid cancer: current state of the art and future directions.
- The Noninvestigational Use of Tyrosine Kinase Inhibitors in Thyroid Cancer: Establishing a Standard for Patient Safety and Monitoring.
- Treatment with Sunitinib for Patients with Progressive Metastatic Pheochromocytomas and Sympathetic Paragangliomas.
- A Randomized Controlled Trial of an Intensive Insulin Regimen in Patients With Hyperglycemic Acute Lymphoblastic Leukemia.
- Differentiated Thyroid cancer: management of patients with radioiodine nonresponsive disease.
- Applying new clinicopathologic characteristics to prognostication in advanced Thyroid carcinoma.
- Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas.
- Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: Re...
- Inhibition of the Ras/Raf/MEK/ERK and RET Kinase Pathways with the Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib ...
- Thyroid oncology.
- Challenges associated with tyrosine kinase inhibitor therapy for metastatic Thyroid cancer.
- Treatment with tyrosine kinase inhibitors for patients with differentiated Thyroid cancer: the M. D. Anderson experience.
- Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Linda...
- Variations in chemotherapy and radiation therapy in a large nationwide and community-based cohort of elderly patients with non-Hodgkin lymphoma.
- Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vi...
- Viral kinetics during the first month of treatment in patients with genoType 1 chronic hepatitis C.
- Diagnostic evaluation of patients with a high suspicion of malignancy: comorbidities and clinical predictors of Cancer.
- Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study.
- Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience.
- Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients ...
- Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia.
- Elderly patients with non-Hodgkin lymphoma who receive chemotherapy are at higher risk for Osteoporosis and fractures.
- Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia.
Schools
University of Puerto Rico Medical Sciences Campus
University Tex
Conditions Treated
- Abnormal Thyroid
- Adrenal Incidentaloma
- Calcium Metabolism Disorders
- Diabetes Type 2
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Choice
- CHAMPVA
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Thrivent Financial
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
University of Texas Health Science Center -
University of Puerto Rico School of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1710071204 | |
| NPPES Provider LastName | CABANILLAS | |
| NPPES Provider FirstName | MARIA | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 418.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710071204 |
| Last Name Of The Provider | CABANILLAS |
| First Name Of The Provider | MARIA |
| View All |
Similar Doctors
|
|
Dr. Frederick E. Rushford, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Sonya Khan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Amin R. Jamal, MD
This Doctor is OpenDoctor Recommended.
|